In addition, the poorest OS was present among the stage II/III colon cancer patients with both XRCC1 Gln and XPD Gln allelic variants and among the stage II/III rectal cancer patients with both the XRCC1 Arg/Arg and XPD Gln allelic variants. Here, ERCC2 is linked to colonic neoplasm.